UK researchers awarded £5.7m to explore epigenetic approaches for antiviral therapies
By
Charlotte Ridler
Summary
Researchers at Barts Cancer Institute, Queen Mary University of London, have been awarded £880,000 as part of a £5.7m national collaborative initiative called epiPRIME. The project explores how epigenetics — the processes controlling gene activation — can be harnessed to strengthen the immune system's ability to fight viruses. Led by Dr Chiara Herzog, the initiative focuses on epigenetically programming resilience through innate memory engineering.
Source

Key quotes
· 3 pulledResearchers at Barts Cancer Institute, Queen Mary University of London, have been awarded funding as part of a £5.7m national collaborative initiative exploring how epigenetics can be harnessed to strengthen our immune system's ability to fight viruses.
Dr Gabriella Ficz, Group Leader at Barts Cancer Institute, will receive £880,000 to support her team's contribution to the epiPRIME project.
The collaboration is led by Dr Chiara Herzog at the University...
You might also wanna read

Study reveals how aging and early life adversity shape DNA methylation across tissues in macaques
This study examines how aging and early life adversity (ELA) affect DNA methylation (DNAm) across different tissues in rhesus macaques from
Children May Hold the Key to a Widespread HIV Cure, Research Suggests
The article explores the groundbreaking research led by Philip Goulder, a pediatrician and immunologist at the University of Oxford, focusin
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
Efficient mRNA delivery to resting T cells to reverse HIV latency
Transgenerational Epigenetic Inheritance: Evidence for Inherited Pathogen Avoidance in C. elegans
This article discusses transgenerational epigenetic inheritance, specifically focusing on evidence that learned avoidance of pathogenic bact
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove

Comments
Sign in to join the conversation.
No comments yet. Be the first.